Evidence map›Paper›PMID 23740278›Full record

Trial reportIntensive care medicine2013

High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial.

Olivier Joannes-Boyau, Patrick M Honoré, Paul Perez, Sean M Bagshaw, Hubert Grand, Jean-Luc Canivet, Antoine Dewitte, Claire Flamens, Wilfried Pujol, Anne-Sophie Grandoulier and 14 more

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06369064 (Comparison of the Effectiveness of Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patients With Acute Renal Injury), which is not on this map. Cited by 167 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed, 12 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06369064 narecruitingnot on this mapstarted 2024, after this paper: background citation

Comparison of the Effectiveness of Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patients With Acute Renal Injury : a Monocentric Controled Randomized Non Inferiority Open Labeled Study

TypeinterventionalSponsorCentre Hospitalier Universitaire de NīmesRan2024 to 2028Enrolled80ConditionsAcute Kidney Injury, Continuous Renal Replacement Therapy, Intensive Care UnitArmsCVVHD Dialysis parameters, CVVHDF Dialysis parameters
3 · Its place in the literature

Who cites it

167 citing papers in PubMed, 12 syntheses or guidelines pooled it, 416 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of High-Volume Hemofiltration in Critically Ill Patients: A Systematic Review and Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. High-volume haemofiltration for sepsis in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  10. Pooled it
  11. Intensity of continuous renal replacement therapy for acute kidney injury.The Cochrane database of systematic reviews · 2016
    Pooled it
  12. Pooled it
  13. Trial
  14. Cytokine hemoadsorption with CytoSorbCritical care (London, England) · 2023
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 3 countries.

Olivier Joannes-BoyauService d'Anesthésie-Réanimation 2, Centre Hospitalier Universitaire (CHU) de Bordeaux, 33000, Bordeaux, France. olivier.joannes-boyau@chu-bordeaux.fr
Patrick M Honoré
Paul Perez
Sean M Bagshaw
Hubert Grand
Jean-Luc Canivet
Antoine Dewitte
Claire Flamens
Wilfried Pujol
Anne-Sophie Grandoulier
Catherine Fleureau
Rita Jacobs
Christophe Broux
Hervé Floch
Olivier Branchard
Stephane Franck
Hadrien Rozé
Vincent Collin
Willem Boer
Joachim Calderon
Bernard Gauche
Herbert D Spapen
Gérard Janvier
Alexandre Ouattara
Centre Hospitalier Universitaire de Bordeaux · FRUniversitair Ziekenhuis Brussel · BECentre Hospitalier Universitaire de Liège · BECentre Hospitalier Universitaire de Tivoli · BEHôpital Albert Michallon · FRHôpital Louis Pradel · FRHôpital Maison Blanche · FRPolyclinique Bordeaux Nord Aquitaine · FRUniversity of Alberta · CAZiekenhuis Oost-Limburg · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSeptic shock is a leading cause of death among critically ill patients, in particular when complicated by acute kidney injury (AKI). Small experimental and human clinical studies have suggested that high-volume haemofiltration (HVHF) may improve haemodynamic profile and mortality. We sought to determine the impact of HVHF on 28-day mortality in critically ill patients with septic shock and AKI.

methodsThis was a prospective, randomized, open, multicentre clinical trial conducted at 18 intensive care units in France, Belgium and the Netherlands. A total of 140 critically ill patients with septic shock and AKI for less than 24 h were enrolled from October 2005 through March 2010. Patients were randomized to either HVHF at 70 mL/kg/h or standard-volume haemofiltration (SVHF) at 35 mL/kg/h, for a 96-h period.

resultsPrimary endpoint was 28-day mortality. The trial was stopped prematurely after enrolment of 140 patients because of slow patient accrual and resources no longer being available. A total of 137 patients were analysed (two withdrew consent, one was excluded); 66 patients in the HVHF group and 71 in the SVHF group. Mortality at 28 days was lower than expected but not different between groups (HVHF 37.9 % vs. SVHF 40.8 %, log-rank test p = 0.94). There were no statistically significant differences in any of the secondary endpoints between treatment groups.

conclusionsIn the IVOIRE trial, there was no evidence that HVHF at 70 mL/kg/h, when compared with contemporary SVHF at 35 mL/kg/h, leads to a reduction of 28-day mortality or contributes to early improvements in haemodynamic profile or organ function. HVHF, as applied in this trial, cannot be recommended for treatment of septic shock complicated by AKI.

Indexed as

Acute Kidney InjuryAgedCritical IllnessFemaleHemofiltrationHumansMaleMiddle AgedProspective StudiesShock, SepticSurvival RateTime Factors

Identifiers

PMID23740278
OpenAlexW2045675252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.